Matthew Zatzman

9PUBLICATIONS
116CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 01, 2025
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA.

Marc J Williams, Ignacio Vázquez-García, Grittney Tam

|Jul 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer.

Andrew McPherson, Ignacio Vázquez-García, Matthew A Myers

|Jul 14, 2025
Complementary modes of resistance to EGFR TKI in lung adenocarcinoma through MAPK activation and cellular plasticity.

Matthew Zatzman, Alvaro Quintanal-Villalonga, Sohrab Salehi

|Jun 04, 2025
Disrupted priming within draining lymph nodes drives immune quiescence in gastric cancer.

Sohrab Salehi, Emily E Stroobant, Hannah Lees

|Sep 05, 2024
Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers.

Laksshman Sundaram, Arvind Kumar, Matthew Zatzman

Pageof 2